Bozkurt D - Search Results

1

What does the dialysate level of matrix metalloproteinase 2 tell us?

Ertilav M, Timur O, Hür E, Bozkurt D, Nar H, Kologlu T, Sen S, Duman S. Ertilav M, et al. Among authors: bozkurt d. Adv Perit Dial. 2011;27:6-10. Adv Perit Dial. 2011. PMID: 22073820

2

What does peritoneal thickness in peritoneal dialysis patients tell us?

Duman S, Ozbek SS, Gunay ES, Bozkurt D, Asci G, Sipahi S, Kirçelli F, Ertilav M, Ozkahya M, Ok E. Duman S, et al. Among authors: bozkurt d. Adv Perit Dial. 2007;23:28-33. Adv Perit Dial. 2007. PMID: 17886598

3

Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model.

Bozkurt D, Taskin H, Sezak M, Biçak S, Sen S, Ok E, Duman S. Bozkurt D, et al. Adv Perit Dial. 2008;24:32-8. Adv Perit Dial. 2008. PMID: 18985998

4

Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model.

Duman S, Bozkurt D, Sipahi S, Sezak M, Ozkan S, Ertilav M, Sen S, Ok E. Duman S, et al. Among authors: bozkurt d. Adv Perit Dial. 2008;24:104-10. Adv Perit Dial. 2008. PMID: 18986012

5

The effects of renin-angiotensin system inhibition on regression of encapsulating peritoneal sclerosis.

Bozkurt D, Cetin P, Sipahi S, Hur E, Nar H, Ertilav M, Sezak M, Duman S. Bozkurt D, et al. Perit Dial Int. 2008 Nov;28 Suppl 5:S38-42. Perit Dial Int. 2008. PMID: 19008539

6

The effects of colchicine on the progression and regression of encapsulating peritoneal sclerosis.

Bozkurt D, Bicak S, Sipahi S, Taskin H, Hur E, Ertilav M, Sen S, Duman S. Bozkurt D, et al. Perit Dial Int. 2008 Nov;28 Suppl 5:S53-7. Perit Dial Int. 2008. PMID: 19008543

7

Can N-acetylcysteine preserve peritoneal function and morphology in encapsulating peritoneal sclerosis?

Bozkurt D, Hur E, Ulkuden B, Sezak M, Nar H, Purclutepe O, Sen S, Duman S. Bozkurt D, et al. Perit Dial Int. 2009 Feb;29 Suppl 2:S202-5. Perit Dial Int. 2009. PMID: 19270218

8

Does immunosuppressive treatment ameliorate morphology changes in encapsulating peritoneal sclerosis?

Bozkurt D, Sipahi S, Cetin P, Hur E, Ozdemir O, Ertilav M, Sen S, Duman S. Bozkurt D, et al. Perit Dial Int. 2009 Feb;29 Suppl 2:S206-10. Perit Dial Int. 2009. PMID: 19270219

9

No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis: comments from around the world.

Bozkurt D, Duman S. Bozkurt D, et al. Int Urol Nephrol. 2010 Mar;42(1):244-5. Int Urol Nephrol. 2010. PMID: 20355282 No abstract available.

10

A novel angiogenesis inhibitor, sunitinib malate, in encapsulating peritoneal sclerosis.

Bozkurt D, Sarsik B, Hur E, Ertilav M, Karaca B, Timur O, Bicak S, Akcicek F, Duman S. Bozkurt D, et al. J Nephrol. 2011 May-Jun;24(3):359-65. doi: 10.5301/JN.2011.6257. J Nephrol. 2011. PMID: 21240876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters